Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cephalon initiates testing of modafinil for excessive daytime sleepiness in sleep apnea sufferers

May 12, 1999

Paxil approved in two major markets for social anxiety disorder

May 12, 1999

Anesta enters partnership with Swedish Orphan for Actiq

May 12, 1999

Safe, dose-dependent MAO-B inhibition in healthy volunteers administered SL-34.0026

May 11, 1999

Potential anxiolytics/antidepressants under development at DuPont

May 11, 1999

Substituted indan derivatives with selective affinity for 5-HT1B receptors

May 11, 1999

Single-isomer valproic acid patented in Japan

May 10, 1999

Licensing opportunity from NIH: BChE inhibitors for Alzheimer's disease Rx, Dx

May 10, 1999

Amarillo's fibromyalgia trial expanded

May 10, 1999

Caspase inhibitor provides neuroprotection in rabbit model of bacterial meningitis

May 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...